A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

News and Media

News and Media
From blogs to magazines to e-newsletters to audio and video, City of Hope offers a wide array of publications that tell our story and share news of advances in the fight against cancer, diabetes and other serious diseases.
 
 

City of Hope has so many breakthroughs in cancer, diabetes and HIV/AIDS – and so many stories – that we’ve tailored our blog, Breakthroughs, to provide something for every reader. Whether the breakthroughs are about medical research, treatment advances or personal triumphs, they’re all connected.
 
City News

Our semiannual magazine features the latest advancements in research and treatment, important news and announcements, events, donor and volunteer recognition, and board and executive appointments.
eHope

Discover the latest about our research, treatment and community events by subscribing to this monthly e-newsletter that offers helpful news you can use.
 

The Helix Blog gives voice to City of Hope graduate students and their research.
 
High Hopes

High Hopes is created by patients for patients. It features personal writings from patients, families and friends, as well as useful tips from a friendly, supportive perspective.
 
HopeCONNECTION

See how your support is making a difference in the fight against cancer in this bimonthly newsletter for friends and supporters of City of Hope.
 
Physician's Bulletin

City of Hope’s Physician’s Bulletin is a publication for healthcare professionals that provides news and information about current research activities and significant trends in cancer treatment options. It is published six times per year under the direction of City of Hope’s Communications Group.
 
Survivorship Connection

A newsletter with health news and tips on how to maintain a healthy lifestyle after childhood cancer. Each issue will have updated information about survivorship issues and will provide links to resources that can help survivors take charge of their future. Published by City of Hope’s Childhood Cancer Survivorship Program.
 

Watch the latest on City of Hope’s research efforts and lifesaving care and experience the best of City of Hope in action.
 


 
 
 
 

 
 
 

 
 
 


 
 
 
 
 
 

Press Releases

From scientific discoveries to promising clinical trials, City of Hope constantly advances new and better ways to improve the lives of people here and throughout the world.
 
You can find the latest information on our research, clinical and educational programs through this listing of current press releases.
 
 
The funding, made possible by philanthropic support, will be used to recruit highly experienced and well-published scientists to join the Department of Diabetes and Metabolic Diseases Research at Beckman Research Institute of City of Hope. Their areas of research will include cell biology, immunology, diabetic complications, gene regulation and obesity
 
 
A burglary that occurred on Feb. 5, 2014, at Sutherland Healthcare Solutions’ office in Torrance resulted in the theft of eight computers, two of which contained personal information about a small percentage of City of Hope patients and their financial guarantors. Sutherland is an outside vendor that contracts with health care providers, including City of Hope, for certain billing services.
 
 
Yuman Fong, M.D., an internationally recognized expert in hepatobiliary cancer and in the use of genetically modified viruses to combat malignant disease, has been named chair of the Department of Surgery at City of Hope.  
 
 
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds’ effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
 
 
Five foundations — Alex’s Lemonade Stand Foundation, Pediatric Cancer Research Foundation (PCRF), The Matthew Larson Foundation for Pediatric Brain Tumors — and two anonymous foundations have announced grants totaling $450,000 in support of Dr. Margarita Gutova’s work, allowing her to continue her preclinical studies using neural stem cells to treat medulloblastoma.
 
 
Noted business leader and physician Norman C. Payson, M.D., has been selected as the new chair of the City of Hope board of directors. He began his three-year term on Jan. 1, taking helm of the institution’s board as the research and treatment center launches a new era of growth and scientific investment.
 
 
A team of City of Hope researchers has received a two-year, $1 million Movember-Prostate Cancer Foundation (PCF) Challenge Award for a double-armed project to treat advanced prostate cancer. The team will be studying two novel agents’ promising ability to stage a combined immunotherapeutic attack against prostate cancer cells, which have previously been resistant to such an effort.
 
 
A $10 million gift from Internet-publishing entrepreneurs Emmet and Toni Stephenson and their daughter Tessa Stephenson Brand will fund the creation of the Toni Stephenson Lymphoma Center at City of Hope, the cornerstone of the institution’s new Hematologic Malignancies Institute.
 
 
City of Hope and Methodist Hospital of Southern California have reached an agreement in which City of Hope will acquire the hospital’s radiation oncology service in Arcadia. The acquisition will expand access to City of Hope’s renowned expertise in radiation therapy and will provide additional convenience for patients seeking specialized cancer services.
 
12/12/2013 - Wishes come true on City of Hope's Rose Parade float
 
For those who have battled cancer, each tomorrow is, in reality, a dream come true. No one knows that better than the 11 cancer survivors who will ride City of Hope’s float at the 125th Rose Parade on New Year’s Day.
 
 
Prestigious Press Ganey awards honor institutions for outstanding patient satisfaction
City of Hope has earned two prestigious Press Ganey awards for its top-quality patient care, marking its fifth consecutive year of being honored by the healthcare industry’s leading performance improvement firm.
 
State-of-the-art facility will bring top-level, comprehensive care to the region’s cancer patients
The brand-new City of Hope | Antelope Valley Cancer and Community Education Center, which will offer a full range of diagnostic and treatment services plus space for conferences and events, will provide Antelope Valley residents with convenient access to City of Hope’s renowned level of care.
 
 
Understanding that innovation and inclusion are vital to an effective partnership with our patients and the community at large, City of Hope is proud to announce the launch of a Chinese-language website, cn.cityofhope.org, with content focused specifically on the needs of Chinese-speaking patients, caregivers and their families.
 
 
Rosen, an internationally known specialist in hematologic malignancies, will set the scientific direction of City of Hope as it embarks on a new era of strategic growth, shaping the research and educational vision for the  $1.2-billion independent biomedical research, treatment and education institution.
 
 
City of Hope and Providence Health & Services, Southern California, announced today their intent to expand access to uniquely compassionate, high-quality oncology services within the Southern California communities served by Providence.
 

A $6.25 million gift from the estate of Billy and Audrey L. Wilder will be used to create two professorships for City of Hope researchers, along with the Wilder Archives Recognition Gallery at City of Hope.
 
 
The 2013-2014 edition of U.S.News & World Report’s “Best Hospitals” has listed City of Hope as one of the best cancer hospitals in the nation. This marks the tenth year that City of Hope has appeared in the cancer rankings of the “Best Hospitals” report, which recognizes elite hospitals in the U.S.
 
 
City of Hope has been notified of the renewal of the prestigious comprehensive cancer center designation from the National Cancer Institute (NCI), a milestone that marks the institution’s 30th year with an NCI designation.
 

The event will pit longtime rival teams Grand Ole Opry and “After MidNite with Blair Garner” against each other on Saturday, June 8, at 9 a.m. at Greer Stadium.
 

The therapy works through a two-part process that simultaneously takes apart the tumors’ support network while stimulating the immune system to attack the cancerous cells.
 

The pledge, which will be used to enhance the scientific core and capacity of City of Hope’s Diabetes Research Center by recruiting a nationally acclaimed leader in the field of diabetes research, was given in honor of Annette and Leonard Shapiro, longtime friends and supporters of groundbreaking diabetes research and of City of Hope.
 

Members of those chapters will be celebrating their contributions to City of Hope, a National Cancer Institute-designated comprehensive cancer center, at a truly unique luncheon on May 5, 2013 at Glendale Country Club in Bellevue, Wash.
 
 
City of Hope, Antelope Valley Hospital, and G. L. Bruno Associates Inc. celebrated the completion of the internal structure of City of Hope | Antelope Valley with a “topping off” ceremony on Friday, April 12, 2013.
 

The Harrows will receive their awards at the West Coast Golf & Tennis Tournament on June 10, 2013 at the Coto de Caza Golf and Racquet Club in Coto de Caza, CA. For more information about the event, please contact Yolanda V. Guerrero at 800-272-2310 or yguerrero@coh.org or log on to the event website at www.cityofhope.org/nhfi/tournament.
 

A former executive vice president at WellPoint Inc., overseeing Comprehensive Health Solutions, Levine will lead the medical foundation in its mission to care for, and provide services to, City of Hope patients.
 

City of Hope has received CEO Cancer Gold Standard™ accreditation, recognizing the organization’s extraordinary commitment to the health of its employees and their families.
 
 
 

Experts Directory

 
As an independent biomedical research and treatment institution, City of Hope specializes in turning research breakthroughs into new treatments. Other specialists are available through the media hotline at 800-888-5323.
 
MEDICINE:
 
BREAST AND WOMEN’S CANCERS:

GASTROINTESTINAL CANCERS:

  • Joseph Kim, M.D.: Director of the Surgical Oncology Training Program; a specialist in head, upper GI and mixed tumor cancers.
  • 626-471-7100; jokim@coh.org
     
HEMATOLOGY:
  • Stephen J. Forman, M.D.: Francis & Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic
    Cell Transplantation; has developed City of Hope into an international leader in leukemia, lymphoma, hematologic malignancy and bone marrow and stem cell transplantation.
  • 626-256-4673, Ext. 62403; sforman@coh.org
     
  • Leslie Popplewell, M.D.: Specialist in hematopoietic and stem cell transplantation, lymphoma and hematologic malignancies.
  • 626-256-4673, Ext. 62416; popplewell@coh.org
 
LUNG CANCER:
 
ONCOLOGY:
  • Cy Aaron Stein, M.D.: Arthur & Rosalie Kaplan Chair in Medical Oncology; specializes in drug therapies and new research; also in prostate, bladder and testicular cancers.
  • 626-471-3890; cstein@coh.org
 
PROSTATE CANCER:

RESEARCH:
 
BASIC SCIENCE:
  • Linda Malkas, Ph.D.: Deputy director of Basic Research; specialist in molecular oncology research and importance of translational research.
  • 626-256-4673, Ext. 68423; lmalkas@coh.org
 
DIABETES:
  • Raynald Samoa, M.D.: Endocrinologist specializing in obesity, childhood obesity.
  • 626-256-4673, Ext. 65208; rsamoa@coh.org
 
HIV/AIDS:
 
VACCINES:
 

Media Relations

City of Hope offers members of the media rapid access to scientific and medical experts, news releases, background research, inspirational human interest stories and much more.

We can connect you with investigators and clinicians who can discuss research, treatment and issues related to cancer and other life-threatening diseases, including HIV/AIDS and diabetes. Experts in gene therapy, stem cell research, biotechnology, genetics, prevention, surgical oncology, pain management, end-of-life care and an array of other subjects are also available.

For breaking health news, interviews, photo requests or the most current information and resources available, please call our Media Hotline at 800-888-5323 or email us at media@coh.org.
 
Media Kit
To obtain a media kit or other information about City of Hope, please contact the Media Relations office for assistance. You may also download electronic versions of materials here:
 
City of Hope's institutional, research, clinical and philanthropic distinctions.
 
City of Hope's key achievements over the last 100 years.
 
Extensive report on clinical, research and fund-raising activities for the fiscal year.
 
 

Media Relations Team

For the latest breaking health news, interviews, photo requests or the most current information and resources available, please call our Media Hotline at 800-888-5323 or email us at media@coh.org.
Donate Online
When you support City of Hope, you help us shorten the time it takes to get from bold, innovative ideas to powerful new medical treatments. Make a gift online now.
 
 
 
 
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Breakthroughs can take many forms. At
City of Hope, they occur in laboratories, in clinics – and in the lives of patients.
Get Social
Connect with us on your favorite social networking and media sites! Show us you support our lifesaving research, treatment and education.
 
 
Subscribe to news by email
Sign up for news and updates from City of Hope by email.  View our privacy policy .
 
 
 
NEWS & UPDATES
  • For breast cancer survivors, a common worry is a recurrence of their cancer. Currently, these patients are screened with regular mammograms, but there’s no way to tell who is more likely to have a recurrence and who is fully cleared of her cancer. A new blood test – reported in Cancer Research, a journal of the...
  • Metastasis — the spreading of cancer cells from a primary tumor site to other parts of the body — generally leads to poorer outcomes for patients, so oncologists and researchers are constantly seeking new ways to detect and thwart this malicious process. Now City of Hope researchers may have identified a substa...
  • Deodorant, plastic bottles, grilled foods, artificial sweeteners, soy products … Do any of these products really cause cancer? With so many cancer myths and urban legends out there, why not ask the experts? They can debunk cancer myths while sharing cancer facts that matter, such as risk factors, preventi...
  • Cancer risk varies by ethnicity, as does the risk of cancer-related death. But the size of those differences can be surprising, highlighting the health disparities that exist among various ethnic groups in the United States. Both cancer incidence and death rates for men are highest among African-Americans, acco...
  • George Winston, known worldwide for his impressionistic, genre-defying music, considers music to be his first language, and admits he often stumbles over words – especially when he attempts languages other than English. There’s one German phrase he’s determined to perfect, however: danke schön. Winston thinks h...
  • Few decisions are more important than those involving health care, and few decisions can have such lasting impact, not only on oneself but on relatives and loved ones. Those choices, especially, should be made in advance – carefully, deliberately, free of pain and stress, and with much weighing of values and pr...
  • Using a card game to make decisions about health care, especially as those decisions relate to the end of life, would seem to be a poor idea. It isn’t. The GoWish Game makes those overwhelming, but all-important decisions not just easy, but natural. On each card of the 36-card deck is listed what seriously ill,...
  • Young adults and adolescents with cancer face unique challenges both during their treatment and afterward. Not only are therapies for children and older adults not always appropriate for them, they also must come to terms with the disease and treatment’s impact on their relationships, finances, school or ...
  • Breast cancer is the most common cancer, other than skin cancer, among women in the United States. It’s also the second-leading cause of cancer death, behind lung cancer. In the past several years, various task force recommendations and studies have questioned the benefits of broad screening guidelines fo...
  • Paternal age and the health effects it has on potential offspring have been the focus of many studies, but few have examined the effect parental age has on the risk of adult-onset hormone-related cancers (breast cancer, ovarian cancer and endometrial cancer). A team of City of Hope researchers, lead by Yani Lu,...
  • Hormone therapy, which is prescribed to women for relief of menopausal symptoms such hot flashes, night sweats and vaginal dryness, has recently seen a decline in popularity (and use) due to its link to an increased risk of breast and endometrial cancer. But City of Hope researchers have found that menopausal h...
  • Myeloproliferative neoplasms can’t be narrowed down to a single cancer, but they can be described by a defining characteristic: too many blood cells. The diseases bring with them a host of frustrating, potentially life-altering symptoms, and management of the diseases and their symptoms is crucial. An upcoming ...
  • More than 18,000 researchers, clinicians, advocates and other professionals will convene at the 105th American Association for Cancer Research (AACR) annual meeting taking place in San Diego from April 5 to 9. With more than 6,000 findings being presented over this five-day period, the amount of information can...
  • Cancer of the prostate is the No. 2 cancer killer of men, behind lung cancer, accounting for more than 29,000 deaths annually in this country. But because prostate cancer advances slowly, good prostate health and early detection can make all the difference. Many prostate cancer tumors don’t require immedi...
  • Despite advances made in detecting and treating nonsmall cell lung cancer, its prognosis remains grim. Even patients whose cancers are caught at their earliest stage have only a 50 percent chance of five-year survival. This poor prognosis is due in part to the cancer’s ability to resist treatment, renderi...